CAS 1207446-68-1
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 Produkte.
Tregalizumab
CAS:Tregalizumab (BT-061) is a humanised monoclonal antibody targeting CD4, binding unique epitopes on CD4 and selectively inducing Treg activation.Reinheit:95% - 99.0% (SDS-PAGE); 98.3% (SEC-HPLC)Farbe und Form:Liquid
